BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 2995968)

  • 21. trans-activation of the simian virus 40 enhancer by a pX product of human T-cell leukemia virus type I.
    Saito S; Nakamura M; Ohtani K; Ichijo M; Sugamura K; Hinuma Y
    J Virol; 1988 Feb; 62(2):644-8. PubMed ID: 2826822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation.
    Hess JL; Small JA; Clements JE
    J Virol; 1989 Jul; 63(7):3001-15. PubMed ID: 2542608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements.
    Derse D
    J Virol; 1987 Aug; 61(8):2462-71. PubMed ID: 3037109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of long terminal repeat sequences of HTLV-III.
    Starcich B; Ratner L; Josephs SF; Okamoto T; Gallo RC; Wong-Staal F
    Science; 1985 Feb; 227(4686):538-40. PubMed ID: 2981438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9753-7. PubMed ID: 2849115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II.
    Shimotohno K; Golde DW; Miwa M; Sugimura T; Chen IS
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1079-83. PubMed ID: 6322188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lor gene and pathogenesis of HTLV-I, -II, and -III.
    Haseltine WA; Sodroski J; Rosen C
    Cancer Res; 1985 Sep; 45(9 Suppl):4545s-4549s. PubMed ID: 2990684
    [No Abstract]   [Full Text] [Related]  

  • 28. Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus.
    Sodroski J; Trus M; Perkins D; Patarca R; Wong-Staal F; Gelmann E; Gallo R; Haseltine WA
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4617-21. PubMed ID: 6087335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes.
    Rosen CA; Sodroski JG; Campbell K; Haseltine WA
    J Virol; 1986 Jan; 57(1):379-84. PubMed ID: 3001360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription.
    Seiki M; Inoue J; Takeda T; Hikikoshi A; Sato M; Yoshida M
    Jpn J Cancer Res; 1985 Dec; 76(12):1127-31. PubMed ID: 3005203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of sequences in the long terminal repeat of avian sarcoma virus required for efficient transcription.
    Gowda S; Rao AS; Kim YW; Guntaka RV
    Virology; 1988 Jan; 162(1):243-7. PubMed ID: 2827383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of homologous viral long terminal repeats by the human immunodeficiency virus type 1 or the human T-cell leukemia virus type I tat proteins occurs in the absence of de novo protein synthesis.
    Jeang KT; Shank PR; Kumar A
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8291-5. PubMed ID: 2847157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.
    Hauber J; Cullen BR
    J Virol; 1988 Mar; 62(3):673-9. PubMed ID: 2828663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long terminal repeat structure of an American isolate of type I human T-cell leukemia virus.
    Josephs SF; Wong-Staal F; Manzari V; Gallo RC; Sodroski JG; Trus MD; Perkins D; Patarca R; Haseltine WA
    Virology; 1984 Dec; 139(2):340-5. PubMed ID: 6097028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
    Rosen CA; Sodroski JG; Kettman R; Burny A; Haseltine WA
    Science; 1985 Jan; 227(4684):320-2. PubMed ID: 2981432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression.
    Nyborg JK; Dynan WS; Chen IS; Wachsman W
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1457-61. PubMed ID: 2830620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
    Siekevitz M; Josephs SF; Dukovich M; Peffer N; Wong-Staal F; Greene WC
    Science; 1987 Dec; 238(4833):1575-8. PubMed ID: 2825351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns.
    Altman R; Harrich D; Garcia JA; Gaynor RB
    J Virol; 1988 Apr; 62(4):1339-46. PubMed ID: 2831395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.